Results 191 to 200 of about 1,690,856 (381)

Impact of Heart Failure and Chronic Kidney Disease on All‐Cause Mortality in Patients Undergoing Coronary Angiography: Results From the Finnish Kardio Multicentre Registry

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Heart failure (HF) and chronic kidney disease (CKD) are common comorbidities among patients undergoing coronary angiography. Both conditions are associated with increased risk of adverse cardiovascular outcomes and mortality. However, the joint prognostic impact of HF and CKD in this patient population remains unclear. Aims We aimed
Jari A. Laukkanen, Jaakko Immonen, Jussi Hernesniemi, Mari Merentie, Ashish H. Shah, Markku Eskola, Sudhir Kurl, Setor K. Kunutsor   +7 more
wiley   +1 more source

Left Main PCI During Cardiac Arrest With Ongoing Lucas CPR

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Percutaneous coronary intervention (PCI) during cardiac arrest presents significant procedural challenges, particularly due to poor imaging and hemodynamic instability. We present the case of a 75‐year‐old man with worsening angina despite optimal medical therapy, who underwent PCI of the left anterior descending (LAD) artery.
Syed Yaseen Naqvi, Syed Mohammad Naqvi
wiley   +1 more source

Contemporary Arterial Access in the Cardiac Catheterization Laboratory.

JACC: Cardiovascular Interventions, 2017
Yader Sandoval, M. Burke, Angie S. Lobo, D. Lips, A. Seto, Ivan J. Chavez, P. Sorajja, Mazen Abu-Fadel, Yale Wang, Anil Poulouse, M. Gössl, M. Mooney, J. Traverse, David Tierney, E. Brilakis   +14 more
semanticscholar   +1 more source

Pediatric Anesthetic Experience in using Tribromethanol for Cardiac Catheterization

, 1960
Albert E. Blundell, ROCCO C. ANDRIELLO, FILIPPO A. BALBONI   +2 more
openalex   +1 more source

Computer processing of cardiac catheterization data. [PDF]

, 1974
J. P. Blackburn, Elphis Christopher, L Cillie, D C Deuchar, Peter Fleming, G A Miller, David Morgan   +6 more
openalex   +1 more source

Feasibility and Safety of Transfemoral Aortic Valve Replacement Using Local Anesthesia in the Catheterization Suite Versus General Anesthesia in the Operation Theater

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background For over a decade, transfemoral transcatheter aortic valve replacements (TF‐TAVR) have been performed at the University Hospital of Nancy. A minimalistic approach to TF‐TAVR, conducted without general anesthesia and entirely percutaneously in a catheterization suite (simplified approach), has been reported to be as safe and ...
Guillaume Abadié, Pierre Adrien Metzdorf, Giuseppe Lauria, Jeanne Varlot, Mazen Elfarra, Florian Eggenspieler, Juan‐Pablo Maureira, Batric Popovic, Edoardo Camenzind   +8 more
wiley   +1 more source

Points from Letters: Cardiac Catheterization [PDF]

, 1970
ET O’Brien
openalex   +1 more source

Progress in Pharmacogenomics Implementation in the United States: Barrier Erosion and Remaining Challenges

Clinical Pharmacology &Therapeutics, EarlyView.
Barriers to incorporating pharmacogenetics into routine clinical practice in the United States are well documented. Initial surveys by the Clinical Pharmacogenetics Implementation Consortium (CPIC) in 2009 and 2010 identified barriers across four key domains that have hindered the widespread adoption of clinical pharmacogenetic testing.
D. Max Smith, Michael P. Douglas, Christina L. Aquilante, Patricia A. Deverka, Beth Devine, Henry M. Dunnenberger, Philip E. Empey, Daniel L. Hertz, Andrew A. Monte, Ann M. Moyer, Jai N. Patel, Victoria M. Pratt, Loren Saulsberry, Stuart A. Scott, Deepak Voora, Erica L. Woodahl, Michelle Whirl‐Carrillo, Akinyemi Oni‐Orisan, on behalf of the Pharmacogenomics Global Research Network (PGRN) Publications Committee   +18 more
wiley   +1 more source

ECMO in the Cardiac Catheterization Lab-Patient Selection Is Key. [PDF]

J Cardiovasc Dev Dis
Tracy W, Ferrell BE, Skendelas JP, Uehara M, Sugiura T.   +4 more
europepmc   +1 more source

CYP2C19 Polymorphisms and Clinical Outcomes Following Percutaneous Coronary Intervention in the Million Veteran Program

Clinical Pharmacology &Therapeutics, EarlyView.
CYP2C19 loss‐of‐function (LOF) alleles decrease the antiplatelet effect of clopidogrel following percutaneous coronary intervention (PCI) in patients presenting with acute coronary syndrome (ACS). The impact of genotype in patients undergoing PCI for stable ischemic heart disease (SIHD) in real‐world populations is less clear.
Catherine Chanfreau‐Coffinier, Kevin A. Friede, Mary E. Plomondon, Kyung Min Lee, Zhenyu Lu, Tia Dinatale, Scott L. DuVall, Jason L. Vassy, Stephen W. Waldo, John H. Cleator, Thomas M. Maddox, Daniel J. Rader, Themistocles L. Assimes, Scott M. Damrauer, Philip S. Tsao, Kyong‐Mi Chang, Deepak Voora, Julie A. Lynch, Jay Giri, VA Million Veteran Program, Sony Tuteja   +20 more
wiley   +1 more source